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Abstract 
Background: Assessment of capacity to consent to treatment is an important legal and ethical 
issue in daily medical practice. ln this study we carefully evaluated the capacity to consent to 
treatment in patients admitted to an acute medical ward using an assessment by members of the 
medical team, the specific Silberfeld's score, the MMSE and an assessment by a senior psychiatrist. 
Methods: Over a 3 month period, 195 consecutive patients of an internai medicine ward in a 
university hospital were included and their capacity to consent was evaluated within 72 hours of 
admission. 
Results: Among the 195 patients, 38 were incapable of consenting to treatment (unconscious 
patients or severe cognitive impairment) and 14 were considered as incapable of consenting by the 
psychiatrist (prevalence of incapacity to consent of 26.7%). Agreement between the psychiatrist's 
evaluation and the Silberfeld questionnaire was poor (sensitivity 35.7%, specificity 91.6%). 
Experienced clinicians showed a higher agreement (sensitivity 57.1 %, specificity 96.5%). A decision 
shared by residents, chief residents and nurses was the best predictor for agreement with the 
psychiatrie assessment (sensitivity 78.6%, specificity 94.3%). 
Conclusion: Prevalence of incapacity to consent to treatment in patients admitted to an acute 
internai medicine ward is high. While the standardized Silberfeld questionnaire and the MMSE are 
not appropriate for the evalua.tion of the capacity to consent in this setting, an assessment by the 
multidisciplinary medical team concurs with the evaluation by a senior psychiatrist. 
Background 
Assessment of the capacity to consent to treatment is an 
important legal and ethîcal issue in medicîne. Providing 
treatment against the wishes of a patient capable of con-
sentîng to treatment violates the princîple of patient 
autonomy and can often violate physicîan beneficence 
[ l]. Accurate assessment of the patient's capacîty to con-
sent is therefore most important for decîsions regarding 
medîcal treatments whîch may have severe side effects or 
even result in fatal outcomes [2]. The capacîty to consent 
to treatment requires the abîlîty to understand and retain 
information, to use this information as part of the decî-
sion-making process and to make free choices. This capac-
îty is specîfic to a partîcular decîsion and can be unstable. 
In busy clinîcal practîce, however, capacity to consent is 
often presumed unless the patient refuses treatment [3] or 
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shows obvious signs of cognitive failure or mental disor-
der. This policy may be the best acceptable clinical and 
ethieal approach considering that it may be very difficult 
to assess the capacity to consent in a situation where 
patients have not yet been exposed to a specific choice 
related to their health. 
While capacity to consent to treatment depends on the 
above-mentioned patient factors, the ability to realize this 
capacity also depends on physician factors [ 4 ], such as 
skills in explaining relevant medieal facts adapted to the 
patient's educational and cultural background. Severa! 
studies have demonstrated difficulties associated with the 
assessment of patients' capacity to consent to treatment 
[5,6] by clinicians who tend to rely on informai clinicat 
impressions [7]. The aim of the present study was (i) to 
identify the prevalence of patients lacking of capacity to 
consent to treatment within the first 72 hours of admis-
sion to a general internai medicine ward of a university 
hospital and (ii) to compare a standardized assessment by 
means of the Silberfeld questionnaire with the assessment 
by a multidisciplinary medieal team or by a senior psychi-
atrist. Previous studies evaluating capacity to consent were 
limited to homogeneous samples based on age [8], 
pathology (psychiatrie disorders (9-11 ], neurologie disor-
ders (12]), or medical setting (patients included in 
research protocols or treated in the ambulatory care set-
tingn[ 13]). 
Methods 
The study was conducted in a general internai medieal 
ward at Lausanne University Hospital (CHUV) during a 
three-month period from June 1 to August 31, 2007. 
Assessment of the capacity to consent to treatment was 
conducted during the first 72 hours following admission. 
The research protocol was accepted bythe hospital's ethies 
committee and written consent was obtained from ail par-
ticipating patients (and/or from their relatives and/ or gen-
eral practitioner if capacity to consent was profoundly 
altered). 
Participants 
Patients who refused to partieipate; who could not read or 
speak French (and therefore were unable fo fill in the Sil-
berfeld questionnaire) or who had major haemodynamie 
instability were excluded. Ail other admitted patients were 
included in the study. Patients with an obvious lack of 
capacity to consent, such as unconscious patients or 
patients who exhibited severe cognitive impairment, (i.e. 
unable to communicate, to recall their date of birth or 
their name) were considered without formai evaluation as 
"incapable to consent to treatment" (as suggested by the 
hospital's ethics committee, informed consent of these 
patients was obtained from their general practitioner or 
their relative). 
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Assessment 
Capacity to consent is specific to a decision and can vary 
over time; a patient is therefore competent or not with 
respect to a specific decision and for a given moment in 
time. The capacity to consent to the treatment or investi-
gation proposed during hospitalisation was evaluated 
specifically for each patient according to the clinieal situ-
ation. Each patient was assessed by a research fellow by 
means of the Mini-Mental State Examination (MMSE) 
and the Silberfeld questionnaire. The French version of 
the MMSE was developed by the Working Croup on Cog-
nitive Evaluations (14]; the original version was devel-
oped by Folstein et al (1975) as a method for grading 
cognitive impairment (score between 0-30, with 0 indicat-
ing the most severe cognitive disturbances and a score 
above 23/30 indieating no severe cognitive impairment) 
[ 15]. The MMSE is a brief, easily administered test of sev-
eral cognitive functions whieh can play a significant role 
in the process of decision-making and, therefore, to con-
sent. The test's validity and reliability have been demon-
strated in psychiatrie, neurologieal, geriatrie, and other 
medical settings (16]. 
The Silberfeld questionnaire assesses adult patient's 
capacity to consent to clinieal treatment using two 
vignettes describing common clinical situations [ 17]. 
Each vignette is read to a patient followed by nine ques-
tions concerning the vignette whieh leads to a score 
between 0 and 10 points (lower scores indieating an 
impaired capacity to consent). The same nine questions 
are then applied to the actual medical situation of the 
patient. Filling in the Silberfeld questionnaire takes about 
30 to 45 minutes. The authors suggest that patients with a 
score equal or superior to 6 are capable of consenting to 
treatment. 
The medieal team, consisting of the resident or fellow, his 
supervisor (a chief resident or a senior physician), the 
nurse in charge of the patient and the referring general 
practitioner were asked to indieate if the patient had or 
had not (yes/no) the capacity to consent to investigations 
or treatment. 
The psychiatrie assessment by a senior psychiatrist was 
based on the guidelines described by Applebaum and 
Grisso (18], whieh evaluate the patient's ability 1) to 
appreciate the situation and its consequences, 2) to under-
stand the relevant information, 3) to manipulate the 
information rationally and 4) to communieate and main-
tain a choice. The psychiatrist also looked for evidence of 
psychopathology affecting capacity, such as delusions. 
The first psychiatrie evaluations were made in the pres-
ence of a psychiatrist who co-developed local guidelines 
for the assessment of patient decision making capacity in 
the general hospital (19]. 
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The research fellow who applied the Silberfeld and who 
asked the medieal team and the general practitioner about 
their clinieal impression and the psychiatrist who evalu-
ated the patients worked independently and did not have 
access to the results of the different assessments. 
Sociodemographie and medical information were 
obtained from the medieal charts of the participating 
patients. 
Statistical analysis 
Correlation between Silberfeld and MMSE scores and 
evaluations of the capacity to consent by members of the 
medical team, referring general practitioner and the psy-
chiatrist were analysed using the SPSS version 9.0. To 
identify overall agreement with the psychiatrie assess-
ment, the receiver-operating curve (ROC) was calculated. 
Data were analysed following the eut-off scores of the 
MMSE and Silberfeld scores as recommended in the liter-
ature [17,20]. 
Results 
Sample 
The sample is described in figure 1. 
Prevalence of incapacity to consent for treatment 
Of the participating patients (n = 195), 26.7% (n = 52) 
were considered as incapable to consent: 38 were uncon-
scious, unable to communicate or cognitively impaired to 
a degree that they were unable to recall their name or date 
ofbirth;14 qualified as incapable according to the psychi-
atrie assessment. 
Study sample 
Sociodemographie and medical characteristics of evalu-
ated patients (n = 157) are listed in Table 1; their mean 
age was 68.6 years old (SD 18.2), 59.2% (n = 93) were 
women, 42.7% (N = 67) were married or lived with some-
one, 14% (n = 22) were single, 15.3% (n = 24) divorced 
and 28% ( n = 44) widowed. The principal reasons for hos-
pitalisation were pulmonary 29.3% (n = 46), cardiovascu-
lar 24.8% (n = 39) and digestive 21% (n = 33) disorders. 
No association between sociodemographie variables and 
capacity to consent was identified. ' 
MMSE 
With the MMSE eut-off score of 23, the prevalence of 
patients with cognitive impairment was 15.3% (n = 24/ 
15 7). A MMSE score below 23 increased the probability of 
incapacity based on the psychiatrie assessment. However 
16 patients were capable of consenting despite cognitive 
impairment on the MMSE. 
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Silberfeld questionnaire 
Agreement between the psychiatrie assessment and the 
Silberfeld questionnaire was poor (kappa 0.249), with a 
sensitivity of 35.7% and a specificity of 91.6% (see Figure 
2); using the Silberfeld score, 12 patients were classified 
false positive and 9 false negative. 
Opinions of the medical team 
We considered the opinions of the medical team (resi-
dent, nurse and supervisor) individually and then the 
majority decision of the medical team. The majority deci-
sion showed the highest agreement with the psychiatrie 
assessment ( specificity and sensitivity of 94.3% and 
78.6%, respectively); when compared to the psychiatrie 
assessment the opinion of the general practitioner 
showed a specificity and sensitivity of 97.4% and 36.4%, 
respectively. The sensitivity and specificity of the various 
evaluations of capacity to consent to treatment are shown 
in Table 2. 
Disagreement among the medical team was observed for 
22 patients ( 14% of the sample ), with half of them ( n = 
11) considered as incapable of consenting to treatment by 
the psychiatrist. 
Discussion 
The aim of this study was to identify the prevalence of 
patients lacking capacity to consent to treatment within 
the first 72 hours of admission to a general internai med-
icine ward of a university hospital. Of the patients ( n = 52; 
26. 7%) who were identified to Jack capacity to consent, a 
majority (n = 38; 19.5%) exhibited obvious incapacity to 
consent, (unconsciousness, severe cognitive impairment); 
an additional 14 (7.2%) patients lacking capacity to con-
sent ( almost a third of ail patients lacl<ing capacity to con-
sent) were identified by the psychiatrist. These findings 
illustrate that besides the easily identifiable patients, some 
patients have to be evaluated in order to determine their 
incapacity to consent. 
70 patients had to be excluded due to the impossibility of 
evaluating them (haemodynamic instability, French not 
spoken) or their refusai to participate to a study. This is a 
limitation of the study since prevalence of patients unable 
to consent may have been influenced by the excluded 
patients; however it is not very probable that ail of them, 
especially the haemodynamieally unstable, were compe-
tent. Patients who refused did so for various reasons 
(fatigue, "no time", etc.) Their refusai was not explicitly 
clarified and documented, since for ethical reasons their 
refusai had to be respected. Although we did not know 
, how many of them refused due to incompetence, we do 
not believe this was often the case. 
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265 patients admitted in 3 
months 
195 patients included 
Patients fully assessed 
n=l57 
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Exclusion (n =70) 
-22 haemodynamic instability 
-20 French not spoken 
-28 other reasons : refusai to participate, 
referra/ to another ward or inability to 
complete ail evaluations 
Evident incapacity to consent to 
treatment (unconsciousness, 
severe cognitive impairment) 
n=38 (19.5%) 
Patients considered 
capable to consent to 
treatment 
n=l43 (73,3%) 
Incapacity to consent to 
treatment by psychiatrie 
assessment 
n=14 (7.2%) 
Figure 1 
The figure describes the recruitment flowchart with the number of patients potentially eligible, the number of 
patients excluded and the main reason for exclusion. For the included patients the number (and the percentage) of 
patients considered to have (i) an evident incapacity to consent to treatment, (ii) an incapacity to consent to treatment based 
on the psychiatrie assessment (iii) and a capacity to consent to treatment are listed. 
The second question of our study was to compare a stand-
ardized assessment (the Silberfeld questionnaire, a tool 
suggested by our institutional directive) with the assess-
ment by a multidisciplinary medical team or by a senior 
psychiatrist. Our main finding was that the clinical team 
is more accurate in assessing capacity to consent than 
either an individual or a standardized test. 
Confirming a previous study, no association was found 
between demographic variables (age, education etc.) and 
capacity to consent to treatment (21]. While capacity to 
consent may possibly be the same across gender and edu-
cational variables, in elderly patients, cognitive deficits 
may be more prevalent and thus influence the capacity to 
consent. Our sample may not be large enough to detect 
such differences. 
Severa! studies have reported the inaccuracy of the stand-
ardized Mini Mental State Exam in determining capacity 
to consent to treatment (7,22,23]. In line with these 
_ results, we observed that the MMSE showed a specificity of 
57.1 % and a sensitivity of 88.8%. For example one patient 
with an MMSE score of 29 was found to lack capacity to 
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Table 1: Persona! and clinical characteristics of patients (n = 157) admitted to the general internai medicine wards who were assessed 
for mental capacity to consent to treatment. 
Age in years +/- Standard deviation 68.6 +/- 18.2 
% N 
Male gender 40.8 64 
Highest level of education 
Primary School 80.9 127 
High school 10.2 16 
College/University 8.9 14 
Place of residence before admission 
lndependent home or flat 73.9 116 
Health care at home 24.2 38 
Nursing home 1.9 3 
Marital Status 
Married/in couple 42.7 67 
single 14.0 22 
Divorced 15.3 24 
Widowed 28.0 44 
Reason for hospitalization 
cardiovascular disorder 24.8 39 
pulmonary disorder 29.3 46 
digestive disorder 21.0 33 
Others disorders (renal, urogenital, metabolic, osteoarticular, neurologie, etc.) 24.9 39 
Co-morbidities 
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Table 1: Persona! and clinical characteristics of patients (n = 157) admitted to the general internai medicine wards who were assessed 
for mental capacity to consent to treatment. (Contînued) 
cardiovascular 
pulrnonary 
digestive 
renal 
rnetabolic 
osteoarticu lar 
urogenital 
neurologie 
psychiatrie 
consent by the psychiatrist; this patient refused the inves-
tigation of a breast tumour because of delusional beliefs. 
If a recommended Silberfeld score of 0-6 had been uti-
lized to identify incapacity to consent, 28% of the 195 
included patients would have been classified as lacking 
capacity to consent (a similar percentage to the prevalence 
found by the psychiatrist); however, the specificity of the 
Silberfeld score was poor. A previous study revealed that 
clinical impressions ( treating physician) were inaccurate 
in determining capacity to consent to treatment [7]. For 
this reason, we included a decision-support tool for the 
assessment of the capacity to consent in this study. We are 
aware that the Silberfeld does not represent the most accu-
rate instrument to evaluate competence We chose the Sil-
berfeld questionnaire because the institutional directive 
of the hospital suggests it be used in daily clinical work 
( other questionnaires supporting clinical judgement were 
considered too time consuming. Although the Silberfeld 
questionnaire offers guiding principles to assess capacity 
to consent (24 ], our findings suggest that this tool is not 
appropria te for the acute care setting. Sin ce the aim of the 
study was not to compare different questionnaires for the 
assessment of capacity to consent, the question whether 
other specific questionnaires designed to 'assist the clini-
cian would have produced better results remains unan-
swered. 
The opinions of clinicians, esp~cially senior physicians, 
were more accurate than the Silberfeld questionnaire. This 
result confirms a prior study reporting that experienced 
physicians were more likely to make accurate assessments 
of capacity to consent than younger physicians, but that 
their assessments could still be improved (25]. In review-
ing the cases with disagreement between supervising phy-
sicians and the psychiatrie assessment, we found that 
70.0 110 
38.9 61 
39.5 62 
38.2 60 
38.9 61 
30.6 48 
23.6 37 
19.I 30 
15.9 25 
fluctuation of patients' clinical status could partially 
explain the differences: of the 11 participants who were 
falsely classified as capable of consenting by the supervi-
sors, two showed a fluctuating clinical status (delirium, 
acute confusional state). A decision shared by the differ-
ent clinical team members was the best predictor for 
agreement with the psychiatrist. However, if disagreement 
among the clinical team occurs (i.e. disagreement 
between one of the residents, chief residents or nurses) a 
psychiatrie consultation may be useful, since half ofthese 
patients (11/22) were found to be incapable of consent-
ing. 
The fact that the general practitioner may not have seen 
the patient for some time may explain the doctor's rela-
tively poor performance in assessing the patient's capacity 
to consent. However, it is important to raise the con-
sciousness of general practitioners with regard to this 
issue, since many of them were surprised and puzzled 
when asked about their patient's capacity to consent to 
treatment 
The psychiatrist assessing patients' capacity to consent was 
a senior staff member (SF). Another limitation of this 
study may arise from the fact that ail the results were com-
pared to a single psychiatrist's opinion. However, the 
study psychiatrist has been specifically trained and based 
her clinical judgment on a standardised guideline. She 
was also supervised for the first evaluation by an experi-
enced liaison psychiatrist (FS) who participated in the 
development of the local guidelines for the assessment of 
capacity to consent. 
Our study was limited to the French speaking patients; 
indeed 7.5% of 265 patients were excluded due to lan-
guage barriers. The fact that the medical setting was not 
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100% 
80% - sensitivity 
specificity 
60% 
40% 
20% 
0 2 3 4 5 6 7 8 9 
Figure 2 
The sensitivity and specificity of the Silberfeld score 
is compared to the psychiatrie assessment for the 
evaluated patients (n = 157). As shown in the figure, a 
eut off score equal or superior to 6 has the best sensitivity 
and specificity. 
able to provide sufficient support for communication 
(translation, cultural mediation), could increase the prev-
alence of patients lacking of ability to realise their capacity 
to consent to treatment. 
Conclusion 
Given the high percentage of patients incapable of con-
senting to treatment and the observed diffi.culty of the 
medical staff in determining the capacity to consent, there 
is a clear need for reliable and valid assessment methods 
of patients admitted to an acute medical ward. This study 
Table 2: Sensitivity and specificity of the Silberfeld, the MMSE 
and various clinical opinions with regards to patients' (n = 157) 
capacity to make decisions compared to the psychiatrist 
assessment. 
Silberfeld 
MMSE 
Resident 
Nurse 
Chief resident internist (CRI) 
Referring general practitioner 
CRI, Resident and Nurse 
(majority decision) 
Sensitivity (%) Specificity (%) 
35.7 91.6 
57.1 88.8 
35.7 96.5 
50.0 94.4 
57.1 96.5 
36.3 97.8 
78.6 94.3 
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demonstrated that a specific tool, such as the Silberfeld 
questionnaire, is less useful than an interdisciplinary eval-
uation by clinicians. Other instruments, such as the 
MacArthur Competence Assessment Tool-Treatment 
(MacCAT-T) [26] will have to be evaluated and compared 
to other methods for the assessment of capacity to consent 
in future studies. The medico-legal contexts with regard to 
capacity to consent may vary in different countries but the 
capacity to consent remains an important ethical and legal 
aspect of patient care in ail settings. Our study demon-
strates that standardized tools, which can evaluate 
patients' capacity to consent, and which have been proven 
to be effective in identifying patients unable to consent 
patients, are currently lacking. Since a clinical judgement 
based on a shared interdisciplinary evaluation appears to 
be the best available option to respect ethico-legal obliga-
tions to assess patient capacity, a sound understanding of 
consent and its accurate evaluation in practice should 
form part of pre and postgraduate training. 
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